|
CCDC75 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.849820E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.816800E-01 |
| Normal-vs-Stage2 |
7.227000E-01 |
| Normal-vs-Stage3 |
9.494300E-02 |
| Normal-vs-Stage4 |
2.222600E-03 |
| Stage1-vs-Stage2 |
5.981200E-01 |
| Stage1-vs-Stage3 |
9.603700E-02 |
| Stage1-vs-Stage4 |
2.075600E-03 |
| Stage2-vs-Stage3 |
1.328370E-01 |
| Stage2-vs-Stage4 |
1.657840E-02 |
| Stage3-vs-Stage4 |
1.971780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.468400E-01 |
| Normal-vs-AfricanAmerican |
2.787300E-04 |
| Normal-vs-Asian |
1.056630E-01 |
| Caucasian-vs-AfricanAmerican |
1.717420E-03 |
| Caucasian-vs-Asian |
2.560500E-02 |
| AfricanAmerican-vs-Asian |
5.357900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.815000E-01 |
| Normal-vs-Female |
1.626170E-01 |
| Male-vs-Female |
6.490400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.180200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.564200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.356200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.844200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.599600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.485400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.579000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.516000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.068600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.573200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.830000E-01 |
| Normal-vs-Grade 2 |
8.506800E-01 |
| Normal-vs-Grade 3 |
6.170100E-02 |
| Normal-vs-Grade 4 |
8.397900E-03 |
| Grade 1-vs-Grade 2 |
7.592800E-01 |
| Grade 1-vs-Grade 3 |
2.587000E-01 |
| Grade 1-vs-Grade 4 |
9.223800E-02 |
| Grade 2-vs-Grade 3 |
3.174000E-02 |
| Grade 2-vs-Grade 4 |
6.158100E-03 |
| Grade 3-vs-Grade 4 |
1.929030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.214570E-01 |
| Normal-vs-ccB subtype |
6.169700E-02 |
| ccA subtype-vs-ccB subtype |
5.377100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.079400E-01 |
| Normal-vs-N1 |
8.932400E-01 |
| N0-vs-N1 |
7.569400E-01 |
|
|
